Neurocysticercosis: A major cause of neurological disease worldwide

Clinical Infectious Diseases

Volumn 24, Issue 2, 1997, Pages 101-115

  White Jr , A Clinton ^a,b  

^a Section of Infectious Diseases   (United States)

^b BEN TAUB GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN CYSTICERCOSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LIFE CYCLE; PARASITE LOCALIZATION; PARASITE TRANSMISSION; PRIORITY JOURNAL; TAENIA SOLIUM;

EID: 20644470110     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.2.101     Document Type: Article

References (20)

1. International League Against Epilepsy. Relationship between epilepsy and tropical diseases. Epilepsia 1994;35:89-93.
2. Shandera WX, White AC Jr, Chen J, Diaz P, Armstrong R. Cysticercosis in Houston, Texas: a report of 112 cases. Medicine (Baltimore) 1994; 73:37-52.
3. Scharf D. Neurocysticercosis. Arch Neurol 1988;45:777-80.
4. McCormick GF. Cysticercosis: review of 230 patients. Bull Clin Neurosci 1985;50:76-101.
5. Mitchell WG, Crawford TO. Intraparenchymal cerebral Cysticercosis in children: diagnosis and treatment. Pediatrics 1988;82:76-82.
6. Earnest MP, Relier LB, Filley CM, Grek AJ. Neurocysticercosis in the United States: 35 cases and a review. Rev Infect Dis 1987;9:961-79.
7. Rosenfeld EA, Byrd SE, Shulman ST. Neurocysticercosis among children in Chicago. Clin Infect Dis 1996;23:262-8.
8. Dixon HBF, Lipscomb FM. Cysticercosis: an analysis and follow-up of 450 cases. Medical Research Council special report series. Vol. 299. London: Her Majesty's Stationery Service, 1961.
9. Tsang VCW, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989; 159:50-9.
10. Tsang VCW, Wilson M. Taenia solium cysticercosis: an under-recognized but serious public health problem. Parasitology Today 1995; 11:124-6.
11. White AC Jr, Baig S, Robinson P. Taenia saginata oncosphere excretory/ secretory peptidases. J Parasitol 1996;82:7-10.
12. Gutierrez Y. Cysticercosis, coenurosis, and sparganosis. In: Diagnostic pathology of parasitic infection with clinical correlation. Philadelphia: Lea & Febiger, 1990:432-59.
13. Aluja AS, Vargas G. The histopathology of porcine cysticercosis. Vet Parasitol 1988;28:65-77.
14. White AC Jr, Tato P, Molinari JL. Host-parasite interactions in Taenia solium Cysticercosis. Infectious Agents and Disease 1992; 1:185-93.
15. White AC Jr, Robinson P, Kuhn R. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chemical Immunology 1996; 7:66.
16. Molinari JL, Tato P, Lara-Aguilera R, White AC Jr. Effects of serum from neurocysticercosis patients on the structure and viability of Taenia solium oncospheres. J Parasitol 1993;79:124-7.
17. Mitchell GF, Goding JW, Rickard MD. Studies on immune responses to larval cestodes in mice. Increased susceptibility of certain mouse strains and hypothymic mice to Taenia taeniaeformis and analysis of passive transfer of resistance with serum. Aust J Exp Biol Med Sci 1977; 55: 165-86.
18. LaClette JP, Shoemaker CB, Richter D, et al. Paramyosin inhibits complement C1. J Immunol 1992; 148:124-8.
19. Suquet C, Green-Edwards C, Leid RW. Isolation and partial characterization of a Taenia taeniaeformis metacestode proteinase inhibitor. Int J Parasitol 1984; 14:165-72.
20. Leid RW, Suquet CM, Tanigoshi L. Parasite defense mechanisms for evasion of host attack: a review. Vet Parasitol 1987;25:147-62.